TAMs-derived IL-6, IL-10, IL-22, and IL-23, together with T-lymphocyte-derived IL-9, IL-10, IL-37, and IL-35 and other cytokines, regulate the immune microenvironment of breast cancer tumors. This evidence concerns the gene IL22 and breast cancer.